Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
Neuropsychopharmacology Reports · 2024
DOI: 10.1002/npr2.12444 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Keisuke Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Dokkyo Medical University, Mibu, Japan. Hauptthemen laut MEDLINE: Migraine Disorders, Antibodies, Monoclonal, Humanized, Dystonic Disorders, Calcitonin Gene-Related Peptide. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recently, calcitonin gene‐related peptide (CGRP) monoclonal antibodies (mAbs) have become available as a prophylactic treatment for migraine and have shown high efficacy and safety in clinical practice. CGRP mAbs have been reported to be effective not only for migraine but also for other comorbidities, such as psychiatric complications in patients with migraine. However, there are no reports examining the effect of CGRP mAbs on dystonia. We treated a patient with comorbid migraine and focal task‐specific dystonia (writer's cramp) with a CGRP mAb (erenumab) because of an increase in monthly migraine days despite the addition of migraine prophylaxis. In this patient, erenumab treatment for 3 months led to improvements in symptoms of both focal dystonia and migraine, suggesting a role for CGRP in the pathophysiology of both conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Dokkyo Medical University, Mibu, Japan.
ORCID-Profile: Keisuke Suzuki
Zitieren
APA
Suzuki, K., Suzuki, S., Fujita, H., Sakuramoto, H., Shioda, M., & Hirata, K. (2024). Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12444
Vancouver
Suzuki K, Suzuki S, Fujita H, Sakuramoto H, Shioda M, Hirata K. Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12444
BibTeX
@article{Suzuki2024,
author = {Suzuki, Keisuke and Suzuki, Shiho and Fujita, Hiroaki and Sakuramoto, Hirotaka and Shioda, Mukuto and Hirata, Koichi},
title = {Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?},
journal = {Neuropsychopharmacology Reports},
year = {2024},
doi = {10.1002/npr2.12444}
}
EUVIMED